TAM
TXG icon

Tiverton Asset Management’s 10x Genomics TXG Stock Holding History

Tiverton Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$403K Buy
+7,998
New +$443K 0.01% 443

Other funds holding TXG

FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Tiverton Asset Management's TXG Position: Q3 2019 in Review

Tiverton Asset Management opened a new position in 10x Genomics (TXG) in Q3 2019: 7,998 shares worth $403K. The stake represents 0.01% of the portfolio and ranks #443 among its holdings.

92 funds tracked by Wall St. Rank hold TXG as of Q3 2019.

  • Tiverton Asset Management held 7,998 shares of 10x Genomics worth $403K as of Q3 2019.
  • 10x Genomics was a new Tiverton Asset Management position in Q3 2019.
  • 10x Genomics made up 0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #443 holding.
  • 92 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.